These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 6164285

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Electropharmacodynamics of N-acetylprocainamide in the immature mammalian heart--evidence for a prominent class III effect in the newborn.
    Dise T, Stolfi A, Yamasaki S, Pickoff AS.
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):96-101. PubMed ID: 1708063
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparative effects of procainamide and its N-acetylated metabolite in conscious dogs with atrioventricular block: plasma concentration-response relationships.
    Boucher M, Dubray C, Paire M, Duchêne-Marullaz P.
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):562-7. PubMed ID: 2447406
    [Abstract] [Full Text] [Related]

  • 8. Electrophysiologic comparative study of procainamide and N-acetylprocainamide in anesthetized dogs: concentration-response relationships.
    Jaillon P, Winkle RA.
    Circulation; 1979 Dec; 60(6):1385-94. PubMed ID: 91451
    [No Abstract] [Full Text] [Related]

  • 9. The discordant influences of infarct healing on the electrophysiologic effects of procainamide and N-acetylprocainamide.
    Nelson SD, Coyne KS, Meimer J.
    J Pharmacol Exp Ther; 1995 Apr; 273(1):315-9. PubMed ID: 7536244
    [Abstract] [Full Text] [Related]

  • 10. N-acetylprocainamide induced changes in refractoriness and monophasic action potentials of the dog heart in situ.
    Amlie JP, Landmark K.
    Cardiovasc Res; 1981 Mar; 15(3):159-63. PubMed ID: 6167356
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic and pharmacodynamic interaction of N-acetyl procainamide and procainamide in humans.
    Funck-Brentano C, Light RT, Lineberry MD, Wright GM, Roden DM, Woosley RL.
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):364-73. PubMed ID: 2476614
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The electrophysiologic effects of procainamide in the immature heart.
    Shih JY, Gillette PC, Kugler JD, Garson A, Fukushige J, Zinner A, Driscoll DJ.
    Pediatr Pharmacol (New York); 1982 Sep; 2(1):65-73. PubMed ID: 7110758
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Electrophysiologic effects of dopamine on the cardiac conduction system (author's transl)].
    Bischoff KO, Hager W, Bödeker K.
    Z Kardiol; 1981 Sep; 70(9):643-51. PubMed ID: 7303803
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the pharmacokinetic and pharmacodynamic properties of procainamide and N-acetylprocainamide.
    Atkinson AJ, Ruo TI, Piergies AA.
    Angiology; 1988 Jul; 39(7 Pt 2):655-67. PubMed ID: 2457345
    [Abstract] [Full Text] [Related]

  • 19. Serum levels and electrophysiological effects of N-acetlyprocainamide as compared with procainamide in the dog heart in situ.
    Amlie JP, Nesje OA, Frislid K, Lunde PK, Landmark K.
    Acta Pharmacol Toxicol (Copenh); 1978 Apr; 42(4):280-6. PubMed ID: 580675
    [Abstract] [Full Text] [Related]

  • 20. Electrophysiologic effects of procainamide in subtherapeutic to therapeutic doses on human atrioventricular conduction system.
    Ogunkelu JB, Damato AN, Akhtar M, Reddy CP, Caracta AR, Lau SH.
    Am J Cardiol; 1976 Apr; 37(5):724-31. PubMed ID: 773160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.